Hypocretins in endocrine regulation

Hypocretins: Integrators of Physiological Functions

Volumn , Issue , 2005, Pages 395-423

  López, Miguel ^a   Tena Sempere, Manuel ^b   García Caballero, Tomás ^a   Señarís, Rosa ^a   Diéguez, Carlos ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84919835305     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-25446-3_27     Document Type: Chapter

References (252)

1. B. J. Everitt and T. Hokfelt. Neuroendocrine anatomy of the hypothalamus, Acta Neurochir. Suppl (Wien.) 47 1-15 (1990).
2. L. L. Bernardis and L. L. Bellinger. The lateral hypothalamic area revisited: neuroanatomy, body weight regulation, neuroendocrinology and metabolism, Neurosci. Biobehav. Rev. 17(2), 141-193 (1993.
3. L. L. Bernardis and L. L. Bellinger. The dorsomedial hypothalamic nucleus revisited: 1998 update, Proc. Soc. Exp. Biol. Med. 218(4), 284-306 (1998.
4. M. Okada. Effect of electrical stimulation of the hypothalamus on the cells of the anterior pituitary gland, Osaka Daigaku Igaku Zasshi 3 365-383 (1954).
5. C. R. Almli and G. T. Golden. Infant rats: effects of lateral hypothalamic destruction, Physiol Behav. 13(1), 81-90 (1974.
6. L. De Lecea, T. S. Kilduff, C. Peyron, X. Gao, P. E. Foye, P. E. Danielson, C. Fukuhara, E. L. Battenberg, V. T. Gautvik, F. S. Bartlett, W. N. Frankel, A. N. Van Den Pol, F. E. Bloom, K. M. Gautvik and J. G. Sutcliffe. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity, Proc. Natl. Acad. Sci. U. S. A 95(1), 322-327 (1998.
7. T. Sakurai, A. Amemiya, M. Ishii, I. Matsuzaki, R. M. Chemelli, H. Tanaka, S. C. Williams, J. A. Richardson, G. P. Kozlowski, S. Wilson, J. R. Arch, R. E. Buckingham, A. C. Haynes, S. A. Carr, R. S. Annan, D. E. McNulty, W. S. Liu, J. A. Terrett, N. A. Elshourbagy, D. J. Bergsma and M. Yanagisawa. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior, Cell 92(4), 573-585 (1998.
8. M. López, L. Seoane, M. C. García, F. Lago, F. F. Casanueva, R. Senarís and C. Diéguez. Leptin regulation of prepro-orexin and orexin receptor mRNA levels in the hypothalamus, Biochem. Biophys. Res. Commun. 269(1), 41-45 (2000.
9. M. López, L. M. Seoane, M. C. García, C. Diéguez and R. Señarís. Neuropeptide Y, but not agouti-related peptide or melanin-concentrating hormone, is a target Peptide for orexin-a feeding actions in the rat hypothalamus, Neuroendocrinology 75(1), 34-44 (2002.
10. J. T. Willie, R. M. Chemelli, C. M. Sinton and M. Yanagisawa. To eat or to sleep? Orexin in the regulation of feeding and wakefulness, Annu. Rev. Neurosci. 24 429-458 (2001).
11. S. Taheri, J. M. Zeitzer and E. Mignot. The role of hypocretins (orexins) in sleep regulation and narcolepsy, Annu. Rev. Neurosci. 25 283-313 (2002).
12. J. M. Siegel. Hypocretin (orexin): Role in Normal Behavior and Neuropathology, Annu. Rev. Psychol. 55 125-148 (2004).
13. J. G. Sutcliffe and L. De Lecea. The hypocretins: setting the arousal threshold, Nat. Rev. Neurosci. 3(5), 339-349 (2002).
14. M. López, C. Diéguez, R. Señarís, in: Recent Research in Endocrinology, edited by S. G. Pandalai (Transworld Research Network, Kerala (India), 2001), pp. 87-98
15. J. P. Kukkonen, T. Holmqvist, S. Ammoun and K. E. Akerman. Functions of the orexinergic/hypocretinergic system, Am. J Physiol Cell Physiol 283(6), C1567-C1591 (2002).
16. M. M. Taylor and W. K. Samson. The other side of the orexins: endocrine and metabolic actions, Am. J Physiol Endocrinol. Metab 284(1), E13-E17 (2003).
17. A. V. Ferguson and W. K. Samson. The orexin/hypocretin system: a critical regulator of neuroendocrine and autonomic function, Front Neuroendocrinol. 24(3), 141-150 (2003).
18. B. J. Murawski and J. Crabbe. Effect of sleep deprivation on plasma 17-hydroxycorticosteroids, J Appl. Physiol 15 280-282 (1960).
19. E. D. Weitzman, D. Fukushima, C. Nogeire, H. Roffwarg, T. F. Gallagher and L. Hellman. Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects, J Clin. Endocrinol. Metab 33(1), 14-22 (1971).
20. J. F. O'Connor, G. Y. Wu, T. F. Gallagher and L. Hellman. The 24-hour plasma thyroxin profile in normal man, J Clin. Endocrinol. Metab 39(4), 765-771 (1974).
21. E. D. Weitzman, C. Nogeire, M. Perlow, D. Fukushima, J. Sassin, P. McGregor and L. Hellman. Effects of a prolonged 3-hour sleep-wake cycle on sleep stages, plasma cortisol, growth hormone and body temperature in man, J Clin. Endocrinol. Metab 38(6), 1018-1030 (1974).
22. U. Beck, V. Brezinova, W. M. Hunter and I. Oswald. Plasma growth hormone and slow wave sleep increase after interruption of sheep, J Clin. Endocrinol. Metab 40(5), 812-815 (1975).
23. A. Miyatake, Y. Morimoto, T. Oishi, N. Hanasaki, Y. Sugita, S. Iijima, Y. Teshima, Y. Hishikawa and Y. Yamamura. Circadian rhythm of serum testosterone and its relation to sleep: comparison with the variation in serum luteinizing hormone, prolactin, and cortisol in normal men, J Clin. Endocrinol. Metab 51(6), 1365-1371 (1980).
24. T. Akerstedt, J. Palmblad, T. B. De La, R. Marana and M. Gillberg. Adrenocortical and gonadal steroids during sleep deprivation, Sleep 3(1), 23-30 (1980).
25. A. Baumgartner, M. Dietzel, B. Saletu, R. Wolf, A. Campos-Barros, K. J. Graf, I. Kurten and U. Mannsmann. Influence of partial sleep deprivation on the secretion of thyrotropin, thyroid hormones, growth hormone, prolactin, luteinizing hormone, follicle stimulating hormone, and estradiol in healthy young women, Psychiatry Res. 48(2), 153-178 (1993).
26. M. Sadamatsu, N. Kato, H. Iida, S. Takahashi, K. Sakaue, K. Takahashi, S. Hashida and E. Ishikawa. The 24-hour rhythms in plasma growth hormone, prolactin and thyroid stimulating hormone: effect of sleep deprivation, J Neuroendocrinol. 7(8), 597-606 (1995).
27. F. Obal, Jr. and J. M. Krueger. The somatotropic axis and sleep, Rev. Neurol. (Paris) 157(11 Pt 2), S12-S15 (2001).
28. C. D. Boethel. Sleep and the endocrine system: new associations to old diseases, Curr. Opin. Pulm. Med. 8(6), 502-505 (2002).
29. E. Van Cauter, F. Latta, A. Nedeltcheva, K. Spiegel, R. Leproult, C. Vandenbril, R. Weiss, J. Mockel, J. J. Legros and G. Copinschi. Reciprocal interactions between the GH axis and sleep, Growth Horm IGF. Res. 14(Suppl A) 10-17 (2004).
30. M. F. Scanlon, B. G. Issa and C. Diéguez. Regulation of growth hormone secretion, Horm. Res. 46(4-5), 149-154 (1996).
31. F. F. Casanueva and C. Diéguez. Neuroendocrine regulation and actions of leptin, Front Neuroendocrinol. 20(4), 317-363 (1999).
32. R. S. Ahima. Leptin and the neuroendocrinology of fasting, Front Horm. Res. 26 42-56 (2000).
33. R. S. Ahima, C. B. Saper, J. S. Flier and J. K. Elmquist. Leptin regulation of neuroendocrine systems, Front Neuroendocrinol. 21(3), 263-307 (2000).
34. J. G. Sutcliffe and L. De Lecea. The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding, J. Neurosci. Res. 62(2), 161-168 (2000).
35. C. Broberger, L. De Lecea, J. G. Sutcliffe and T. Hokfelt. Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems, J. Comp Neurol. 402(4), 460-474 (1998).
36. C. F. Elias, C. B. Saper, E. Maratos-Flier, N. A. Tritos, C. Lee, J. Kelly, J. B. Tatro, G. E. Hoffman, M. M. Ollmann, G. S. Barsh, T. Sakurai, M. Yanagisawa and J. K. Elmquist. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area, J. Comp Neurol. 402(4), 442-459 (1998.
37. T. Nambu, T. Sakurai, K. Mizukami, Y. Hosoya, M. Yanagisawa and K. Goto. Distribution of orexin neurons in the adult rat brain, Brain Res. 827(1-2), 243-260 (1999).
38. Y. Date, Y. Ueta, H. Yamashita, H. Yamaguchi, S. Matsukura, K. Kangawa, T. Sakurai, M. Yanagisawa and M. Nakazato. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems, Proc. Natl. Acad. Sci. U. S. A 96(2), 748-753 (1999).
39. T. L. Horvath, S. Diano and A. N. Van Den Pol. Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations, J. Neurosci. 19(3), 1072-1087 (1999).
40. A. N. Van Den Pol. Hypothalamic hypocretin (orexin): robust innervation of the spinal cord, J. Neurosci. 19(8), 3171-3182 (1999).
41. N. A. Tritos, J. W. Mastaitis, E. Kokkotou and E. Maratos-Flier. Characterization of melanin concentrating hormone and preproorexin expression in the murine hypothalamus, Brain Res. 895(1-2), 160-166 (2001).
42. A. B. Reddy, A. S. Cronin, H. Ford and F. J. Ebling. Seasonal regulation of food intake and body weight in the male Siberian hamster: studies of hypothalamic orexin (hypocretin), neuropeptide Y (NPY) and proopiomelanocortin (POMC), Eur. J. Neurosci. 11(9), 3255-3264 (1999).
43. P. A. McGranaghan and H. D. Piggins. Orexin A-like immunoreactivity in the hypothalamus and thalamus of the Syrian hamster (Mesocricetus auratus) and Siberian hamster (Phodopus sungorus), with special reference to circadian structures, Brain Res. 904(2), 234-244 (2001).
44. E. M. Mintz, A. N. Van Den Pol, A. A. Casano and H. E. Albers. Distribution of hypocretin-(orexin) immunoreactivity in the central nervous system of Syrian hamsters (Mesocricetus auratus), J. Chem. Neuroanat. 21(3), 225-238 (2001).
45. A. L. Kirchgessner. Orexins in the brain-gut axis, Endocr. Rev. 23(1), 1-15 (2002).
46. C. M. Novak and H. E. Albers. Localization of hypocretin-like immunoreactivity in the brain of the diurnal rodent, Arvicanthis niloticus, J. Chem. Neuroanat. 23(1), 49-58 (2002).
47. J. H. Zhang, S. Sampogna, F. R. Morales and M. H. Chase. Orexin (hypocretin)-like immunoreactivity in the cat hypothalamus: a light and electron microscopic study, Sleep 24(1), 67-76 (2001).
48. S. J. Fung, J. Yamuy, S. Sampogna, F. R. Morales and M. H. Chase. Hypocretin (orexin) input to trigeminal and hypoglossal motoneurons in the cat: a double-labeling immunohistochemical study, Brain Res. 903(1-2), 257-262 (2001).
49. J. H. Zhang, S. Sampogna, F. R. Morales and M. H. Chase. Co-localization of hypocretin-1 and hypocretin-2 in the cat hypothalamus and brainstem, Peptides 23(8), 1479-1483 (2002).
50. J. Iqbal, S. Pompolo, T. Sakurai and I. J. Clarke. Evidence that Orexin-Containing Neurones Provide Direct Input to Gonadotropin-Releasing Hormone Neurones in the Ovine Hypothalamus, J. Neuroendocrinol. 13(12), 1033-1041 (2001).
51. S. Diano, B. Horvath, H. F. Urbanski, P. Sotonyi and T. L. Horvath. Fasting activates the nonhuman primate hypocretin (orexin) system and its postsynaptic targets, Endocrinology 144(9), 3774-3778 (2003).
52. C. Peyron, J. Faraco, W. Rogers, B. Ripley, S. Overeem, Y. Charnay, S. Nevsimalova, M. Aldrich, D. Reynolds, R. Albin, R. Li, M. Hungs, M. Pedrazzoli, M. Padigaru, M. Kucherlapati, J. Fan, R. Maki, G. J. Lammers, C. Bouras, R. Kucherlapati, S. Nishino and E. Mignot. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains, Nat. Med. 6(9), 991-997 (2000).
53. T. C. Thannickal, R. Y. Moore, R. Nienhuis, L. Ramanathan, S. Gulyani, M. Aldrich, M. Cornford and J. M. Siegel. Reduced number of hypocretin neurons in human narcolepsy, Neuron 27(3), 469-474 (2000).
54. T. C. Thannickal, J. M. Siegel, R. Nienhuis and R. Y. Moore. Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy, Brain Pathol. 13(3), 340-351 (2003).
55. L. Galas, H. Vaudry, B. Braun, A. N. Van Den Pol, L. De Lecea, J. G. Sutcliffe and N. Chartrel. Immunohistochemical localization and biochemical characterization of hypocretin/orexin-related peptides in the central nervous system of the frog Rana ridibunda, J. Comp Neurol. 429(2), 242-252 (2001).
56. M. Shibahara, T. Sakurai, T. Nambu, T. Takenouchi, H. Iwaasa, S. I. Egashira, M. Ihara and K. Goto. Structure, tissue distribution, and pharmacological characterization of Xenopus orexins, Peptides 20(10), 1169-1176 (1999).
57. C. Peyron, D. K. Tighe, A. N. Van Den Pol, L. De Lecea, H. C. Heller, J. G. Sutcliffe and T. S. Kilduff. Neurons containing hypocretin (orexin) project to multiple neuronal systems, J. Neurosci. 18(23), 9996-10015 (1998).
58. P. Trivedi, H. Yu, D. J. MacNeil, L. H. Van Der Ploeg and X. M. Guan. Distribution of orexin receptor mRNA in the rat brain, FEBS Lett. 438(1-2), 71-75 (1998).
59. X. Y. Lu, D. Bagnol, S. Burke, H. Akil and S. J. Watson. Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting, Horm. Behav. 37(4), 335-344 (2000).
60. J. N. Marcus, C. J. Aschkenasi, C. E. Lee, R. M. Chemelli, C. B. Saper, M. Yanagisawa and J. K. Elmquist. Differential expression of orexin receptors 1 and 2 in the rat brain, J. Comp Neurol. 435(1), 6-25 (2001).
61. M. Backberg, G. Hervieu, S. Wilson and B. Meister. Orexin receptor-1 (OX-R1) immunoreactivity in chemically identified neurons of the hypothalamus: focus on orexin targets involved in control of food and water intake, Eur. J. Neurosci. 15(2), 315-328 (2002).
62. G. J. Hervieu, J. E. Cluderay, D. C. Harrison, J. C. Roberts and R. A. Leslie. Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord, Neuroscience 103(3), 777-797 (2001).
63. R. E. Campbell, K. L. Grove and M. S. Smith. Gonadotropin-releasing hormone neurons coexpress orexin 1 receptor immunoreactivity and receive direct contacts by orexin fibers, Endocrinology 144(4), 1542-1548 (2003).
64. J. E. Cluderay, D. C. Harrison and G. J. Hervieu. Protein distribution of the orexin-2 receptor in the rat central nervous system, Regul. Pept. 104(1-3), 131-144 (2002).
65. Y. Date, M. S. Mondal, S. Matsukura, Y. Ueta, H. Yamashita, H. Kaiya, K. Kangawa and M. Nakazato. Distribution of orexin/hypocretin in the rat median eminence and pituitary, Brain Res. Mol. Brain Res. 76(1), 1-6 (2000).
66. O. Johren, S. J. Neidert, M. Kummer, A. Dendorfer and P. Dominiak. Prepro-orexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats, Endocrinology 142(8), 3324-3331 (2001).
67. M. Blanco, R. Gallego, T. García-Caballero, C. Diéguez and A. Beiras. Cellular localization of orexins in human anterior pituitary, Histochem. Cell Biol. 120(4), 259-264 (2003).
68. M. Blanco, M. López, T. García-Caballero, R. Gallego, A. Vázquez-Boquete, G. Morel, R. M. Señarís, F. Casanueva, C. Diéguez and A. Beiras. Cellular localization of orexin receptors in human pituitary, J. Clin. Endocrinol. Metab 86(4), 1616-1619 (2001).
69. O. Johren, N. Bruggemann, A. Dendorfer and P. Dominiak. Gonadal steroids differentially regulate the messenger ribonucleic acid expression of pituitary orexin type 1 receptors and adrenal orexin type 2 receptors, Endocrinology 144(4), 1219-1225 (2003).
70. M. López, R. Senarís, R. Gallego, T. García-Caballero, F. Lago, L. Seoane, F. Casanueva and C. Diéguez. Orexin receptors are expressed in the adrenal medulla of the rat, Endocrinology 140(12), 5991-5994 (1999).
71. H. S. Randeva, E. Karteris, D. Grammatopoulos and E. W. Hillhouse. Expression of orexin-A and functional orexin type 2 receptors in the human adult adrenals: implications for adrenal function and energy homeostasis, J. Clin. Endocrinol. Metab 86(10), 4808-4813 (2001).
72. M. Nakabayashi, T. Suzuki, K. Takahashi, K. Totsune, Y. Muramatsu, C. Kaneko, F. Date, J. Takeyama, A. D. Darnel, T. Moriya and H. Sasano. Orexin-A expression in human peripheral tissues, Mol. Cell Endocrinol. 205(1-2), 43-50 (2003).
73. L. K. Malendowicz, A. Hochol, A. Ziolkowska, M. Nowak, L. Gottardo and G. G. Nussdorfer. Prolonged orexin administration stimulates steroid-hormone secretion, acting directly on the rat adrenal gland, Int. J. Mol. Med. 7(4), 401-404 (2001).
74. T. Nanmoku, K. Isobe, T. Sakurai, A. Yamanaka, K. Takekoshi, Y. Kawakami, K. Goto and T. Nakai. Effects of orexin on cultured porcine adrenal medullary and cortex cells, Regul. Pept. 104(1-3), 125-130 (2002).
75. G. Mazzocchi, L. K. Malendowicz, F. Aragona, P. Rebuffat, L. Gottardo and G. G. Nussdorfer. Human pheochromocytomas express orexin receptor type 2 gene and display an in vitro secretory response to orexins A and B, J. Clin. Endocrinol. Metab 86(10), 4818-4821 (2001).
76. G. Mazzocchi, L. K. Malendowicz, L. Gottardo, F. Aragona and G. G. Nussdorfer. Orexin A stimulates cortisol secretion from human adrenocortical cells through activation of the adenylate cyclase-dependent signaling cascade, J. Clin. Endocrinol. Metab 86(2), 778-782 (2001).
77. M. Blanco, T. García-Caballero, M. Fraga, R. Gallego, J. Cuevas, J. Forteza, A. Beiras and C. Diéguez. Cellular localization of orexin receptors in human adrenal gland, adrenocortical adenomas and pheochromocytomas, Regul. Pept. 104(1-3), 161-165 (2002).
78. M. L. Barreiro, R. Pineda, V. M. Navarro, M. López, J. S. Suominen, L. Pinilla, R. Senarís, J. Toppari, E. Aguilar, C. Diéguez and M. Tena-Sempere. Orexin 1 receptor messenger ribonucleic Acid expression and stimulation of testosterone secretion by orexin-a in rat testis, Endocrinology 145(5), 2297-2306 (2004).
79. E. Karteris, J. Chen and H. S. Randeva. Expression of human prepro-orexin and signaling characteristics of orexin receptors in the male reproductive system, J Clin. Endocrinol. Metab 89(4), 1957-1962 (2004).
80. A. L. Kirchgessner and M. Liu. Orexin synthesis and response in the gut, Neuron 24(4), 941-951 (1999).
81. M. J. De Miguel and M. A. Burrell. Immunocytochemical Detection of Orexin A in Endocrine Cells of the Developing Mouse Gut, J. Histochem. Cytochem. 50(1), 63-70 (2002).
82. E. Naslund, M. Ehrstrom, J. Ma, P. M. Hellstrom and A. L. Kirchgessner. Localization and effects of orexin on fasting motility in the rat duodenum, Am. J Physiol Gastrointest. Liver Physiol 282(3), G470-G479 (2002).
83. R. Ouedraogo, E. Naslund and A. L. Kirchgessner. Glucose regulates the release of orexin-a from the endocrine pancreas, Diabetes 52(1), 111-117 (2003).
84. J. D. Mikkelsen, F. Hauser, L. De Lecea, J. G. Sutcliffe, T. S. Kilduff, C. Calgari, P. Pevet and V. Simonneaux. Hypocretin (orexin) in the rat pineal gland: a central transmitter with effects on noradrenaline-induced release of melatonin, Eur. J. Neurosci. 14(3), 419-425 (2001).
85. Z. Arihara, K. Takahashi, O. Murakami, K. Totsune, M. Sone, F. Satoh, S. Ito and T. Mouri. Immunoreactive orexin-A in human plasma, Peptides 22(1), 139-142 (2001).
86. G. Komaki, Y. Matsumoto, H. Nishikata, K. Kawai, T. Nozaki, M. Takii, H. Sogawa and C. Kubo. Orexin-A and leptin change inversely in fasting non-obese subjects, Eur. J. Endocrinol. 144(6), 645-651 (2001).
87. M. A. Dalal, A. Schuld, M. Haack, M. Uhr, P. Geisler, I. Eisensehr, S. Noachtar and T. Pollmacher. Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients, Neurology 56(12), 1749-1751 (2001).
88. T. Matsumura, M. Nakayama, A. Nomura, A. Naito, K. Kamahara, K. Kadono, M. Inoue, T. Homma and K. Sekizawa. Age-related changes in plasma orexin-A concentrations, Exp. Gerontol. 37(8-9), 1127 (2002).
89. J. A. Adam, P. P. Menheere, F. M. Van Dielen, P. B. Soeters, W. A. Buurman and J. W. Greve. Decreased plasma orexin-A levels in obese individuals, Int. J. Obes. Relat Metab Disord. 26(2), 274-276 (2002).
90. T. Sugimoto, Y. Nagake, S. Sugimoto, S. Akagi, H. Ichikawa, Y. Nakamura, N. Ogawa and H. Makino. Plasma orexin concentrations in patients on hemodialysis, Nephron 90(4), 379-383 (2002).
91. S. Higuchi, A. Usui, M. Murasaki, S. Matsushita, N. Nishioka, A. Yoshino, T. Matsui, H. Muraoka, Y. Ishizuka, S. Kanba and T. Sakurai. Plasma orexin-A is lower in patients with narcolepsy, Neurosci. Lett. 318(2), 61-64 (2002).
92. S. W. Kok, A. E. Meinders, S. Overeem, G. J. Lammers, F. Roelfsema, M. Frolich and H. Pijl. Reduction of plasma leptin levels and loss of its circadian rhythmicity in hypocretin (orexin)-deficient narcoleptic humans, J. Clin. Endocrinol. Metab 87(2), 805-809 (2002).
93. J. L. Li, F. L. Zheng, H. B. Tan, S. Y. Yin, J. H. Yang, Y. Li and Y. F. Bu. [Orexin A and neuropeptide Y levels in plasma and hypothalamus of rats with chronic renal failure], Zhonghua Yi. Xue. Za Zhi. 83(11), 992-995 (2003).
94. M. Palkovits, M. J. Brownstein and W. Vale. Distribution of corticotropin-releasing factor in rat brain, Fed. Proc. 44(1 Pt 2), 215-219 (1985).
95. S. Welle and G. D. Coover. Meal-induced decreases in serum corticosterone in the lateral hypothalamic syndrome, Physiol Behav. 23(3), 547-555 (1979).
96. M. Kuru, Y. Ueta, R. Serino, M. Nakazato, Y. Yamamoto, I. Shibuya and H. Yamashita. Centrally administered orexin/hypocretin activates HPA axis in rats, Neuroreport 11(9), 1977-1980 (2000).
97. M. J. Follwell and A. V. Ferguson. Cellular mechanisms of orexin actions on paraventricular nucleus neurones in rat hypothalamus, J. Physiol 545(Pt 3), 855-867 (2002).
98. W. K. Samson, M. M. Taylor, M. Follwell and A. V. Ferguson. Orexin actions in hypothalamic paraventricular nucleus: physiological consequences and cellular correlates, Regul. Pept. 104(1-3), 97-103 (2002).
99. T. Shirasaka, S. Miyahara, T. Kunitake, Q. H. Jin, K. Kato, M. Takasaki and H. Kannan. Orexin depolarizes rat hypothalamic paraventricular nucleus neurons, Am. J. Physiol Regul. Integr. Comp Physiol 281(4), R1114-R1118 (2001).
100. K. A. Al Barazanji, S. Wilson, J. Baker, D. S. Jessop and M. S. Harbuz. Central orexin-A activates hypothalamic-pituitary-adrenal axis and stimulates hypothalamic corticotropin releasing factor and arginine vasopressin neurones in conscious rats, J. Neuroendocrinol. 13(5), 421-424 (2001).
101. J. J. Hagan, R. A. Leslie, S. Patel, M. L. Evans, T. A. Wattam, S. Holmes, C. D. Benham, S. G. Taylor, C. Routledge, P. Hemmati, R. P. Munton, T. E. Ashmeade, A. S. Shah, J. P. Hatcher, P. D. Hatcher, D. N. Jones, M. I. Smith, D. C. Piper, A. J. Hunter, R. A. Porter and N. Upton. Orexin A activates locus coeruleus cell firing and increases arousal in the rat, Proc. Natl. Acad. Sci. U. S. A 96(19), 10911-10916 (1999).
102. M. Jaszberenyi, E. Bujdoso, I. Pataki and G. Telegdy. Effects of orexins on the hypothalamic-pituitaryadrenal system, J. Neuroendocrinol. 12(12), 1174-1178 (2000).
103. M. Jaszberenyi, E. Bujdoso and G. Telegdy. The role of neuropeptide Y in orexin-induced hypothalamicpituitary-adrenal activation, J. Neuroendocrinol. 13(5), 438-441 (2001).
104. S. H. Russell, C. J. Small, C. L. Dakin, C. R. Abbott, D. G. Morgan, M. A. Ghatei and S. R. Bloom. The central effects of orexin-A in the hypothalamic-pituitary-adrenal axis in vivo and in vitro in male rats, J. Neuroendocrinol. 13(6), 561-566 (2001).
105. H. Volkoff and R. E. Peter. Interactions between orexin A, NPY and galanin in the control of food intake of the goldfish, Carassius auratus, Regul. Pept. 101(1-3), 59-72 (2001).
106. R. E. Campbell, M. S. Smith, S. E. Allen, B. E. Grayson, J. M. Ffrench-Mullen and K. L. Grove. Orexin neurons express a functional pancreatic polypeptide Y4 receptor, J Neurosci. 23(4), 1487-1497 (2003).
107. S. Pu, M. R. Jain, P. S. Kalra and S. P. Kalra. Orexins, a novel family of hypothalamic neuropeptides, modulate pituitary luteinizing hormone secretion in an ovarian steroid-dependent manner, Regul. Pept. 78(1-3), 133-136 (1998).
108. S. H. Russell, C. J. Small, A. R. Kennedy, S. A. Stanley, A. Seth, K. G. Murphy, S. Taheri, M. A. Ghatei and S. R. Bloom. Orexin a interactions in the hypothalamo-pituitary gonadal axis, Endocrinology 142(12), 5294-5302 (2001).
109. Y. C. Hsueh, S. M. Cheng and J. T. Pan. Fasting stimulates tuberoinfundibular dopaminergic neuronal activity and inhibits prolactin secretion in oestrogen-primed ovariectomized rats: involvement of orexin a and neuropeptide y, J. Neuroendocrinol. 14(9), 745-752 (2002).
110. M. Jaszberenyi, E. Bujdoso, E. Kiss, I. Pataki and G. Telegdy. The role of NPY in the mediation of orexininduced hypothermia, Regul. Pept. 104(1-3), 55-59 (2002).
111. M. Szekely, E. Petervari, M. Balasko, I. Hernadi and B. Uzsoki. Effects of orexins on energy balance and thermoregulation, Regul. Pept. 104(1-3), 47-53 (2002).
112. A. Yamanaka, K. Kunii, T. Nambu, N. Tsujino, A. Sakai, I. Matsuzaki, Y. Miwa, K. Goto and T. Sakurai. Orexin-induced food intake involves neuropeptide Y pathway, Brain Res. 859(2), 404-409 (2000).
113. M. R. Jain, T. L. Horvath, P. S. Kalra and S. P. Kalra. Evidence that NPY Y1 receptors are involved in stimulation of feeding by orexins (hypocretins) in sated rats, Regul. Pept. 87(1-3), 19-24 (2000).
114. T. Ida, K. Nakahara, T. Kuroiwa, K. Fukui, M. Nakazato, T. Murakami and N. Murakami. Both corticotropin releasing factor and neuropeptide Y are involved in the effect of orexin (hypocretin) on the food intake in rats, Neurosci. Lett. 293(2), 119-122 (2000).
115. M. G. Dube, T. L. Horvath, P. S. Kalra and S. P. Kalra. Evidence of NPY Y5 receptor involvement in food intake elicited by orexin A in sated rats, Peptides 21(10), 1557-1560 (2000).
116. L. K. Malendowicz, N. Jedrzejczak, A. S. Belloni, M. Trejter, A. Hochol and G. G. Nussdorfer. Effects of orexins A and B on the secretory and proliferative activity of immature and regenerating rat adrenal glands, Histol. Histopathol. 16(3), 713-717 (2001).
117. L. K. Malendowicz, C. Tortorella and G. G. Nussdorfer. Orexins stimulate corticosterone secretion of rat adrenocortical cells, through the activation of the adenylate cyclase-dependent signaling cascade, J. Steroid Biochem. Mol. Biol. 70(4-6), 185-188 (1999).
118. T. Ida, K. Nakahara, T. Murakami, R. Hanada, M. Nakazato and N. Murakami. Possible involvement of orexin in the stress reaction in rats, Biochem. Biophys. Res. Commun. 270(1), 318-323 (2000).
119. W. K. Samson and M. M. Taylor. Hypocretin/orexin suppresses corticotroph responsiveness in vitro, Am. J. Physiol Regul. Integr. Comp Physiol 281(4), R1140-R1145 (2001).
120. C. T. Chen, L. L. Hwang, J. K. Chang and N. J. Dun. Pressor effects of orexins injected intracisternally and to rostral ventrolateral medulla of anesthetized rats, Am. J. Physiol Regul. Integr. Comp Physiol 278(3), R692-R697 (2000).
121. W. K. Samson, B. Gosnell, J. K. Chang, Z. T. Resch and T. C. Murphy. Cardiovascular regulatory actions of the hypocretins in brain, Brain Res. 831(1-2), 248-253 (1999).
122. T. Shirasaka, M. Nakazato, S. Matsukura, M. Takasaki and H. Kannan. Sympathetic and cardiovascular actions of orexins in conscious rats, Am. J. Physiol 277(6 Pt 2), R1780-R1785 (1999).
123. P. J. Brunton and J. A. Russell. Hypothalamic-pituitary-adrenal responses to centrally administered orexin-A are suppressed in pregnant rats, J Neuroendocrinol. 15(7), 633-637 (2003).
124. B. B. Gallagher. Regulation of cortisol secretion in Parkinson's syndrome and narcolepsy, J Clin. Endocrinol. Metab 32(6), 796-800 (1971).
125. S. W. Kok, F. Roelfsema, S. Overeem, G. J. Lammers, R. L. Strijers, M. Frolich, A. E. Meinders and H. Pijl. Dynamics of the pituitary-adrenal ensemble in hypocretin-deficient narcoleptic humans: blunted basal adrenocorticotropin release and evidence for normal time-keeping by the master pacemaker, J Clin. Endocrinol. Metab 87(11), 5085-5091 (2002).
126. K. Morita, A. Kuwada, H. Fujihara, Y. Morita and H. Sei. Changes in the expression of steroid metabolism-related genes in rat adrenal glands during selective REM sleep deprivation, Life Sci. 72(17), 1973-1982 (2003).
127. J. R. Davidson, H. Moldofsky and F. A. Lue. Growth hormone and cortisol secretion in relation to sleep and wakefulness, J Psychiatry Neurosci. 16(2), 96-102 (1991).
128. A. N. Vgontzas, G. Mastorakos, E. O. Bixler, A. Kales, P. W. Gold and G. P. Chrousos. Sleep deprivation effects on the activity of the hypothalamic-pituitary-adrenal and growth axes: potential clinical implications, Clin. Endocrinol. (Oxf) 51(2), 205-215 (1999).
129. F. Chapotot, A. Buguet, C. Gronfier and G. Brandenberger. Hypothalamo-pituitary-adrenal axis activity is related to the level of central arousal: effect of sleep deprivation on the association of high-frequency waking electroencephalogram with cortisol release, Neuroendocrinology 73(5), 312-321 (2001).
130. A. Stricker-Krongrad and B. Beck. Modulation of hypothalamic hypocretin/orexin mRNA expression by glucocorticoids, Biochem. Biophys. Res. Commun. 296(1), 129-133 (2002).
131. D. L. Drazen, L. M. Coolen, A. D. Strader, M. D. Wortman, S. C. Woods and R. J. Seeley. Differential effects of adrenalectomy on melanin-concentrating hormone and orexin A, Endocrinology (2004) (EPub 24/3/2004 as doi:10.1210/en2003-1760).
132. T. Nanmoku, K. Isobe, T. Sakurai, A. Yamanaka, K. Takekoshi, Y. Kawakami, K. Ishii, K. Goto and T. Nakai. Orexins suppress catecholamine synthesis and secretion in cultured PC12 cells, Biochem. Biophys. Res. Commun. 274(2), 310-315 (2000.
133. K. Matsumura, T. Tsuchihashi and I. Abe. Central orexin-A augments sympathoadrenal outflow in conscious rabbits, Hypertension 37(6), 1382-1387 (2001).
134. T. Shirasaka, T. Kunitake, M. Takasaki and H. Kannan. Neuronal effects of orexins: relevant to sympathetic and cardiovascular functions, Regul. Pept. 104(1-3), 91-95 (2002).
135. P. Smith, B. Connolly and A. Ferguson. Microinjection of orexin into the rat nucleus tractus solitarius causes increases in blood pressure, Brain Res. 950(1-2), 261 (2002).
136. P. E. Sawchenko, L. W. Swanson, J. Rivier and W. W. Vale. The distribution of growth-hormone-releasing factor (GRF) immunoreactivity in the central nervous system of the rat: an immunohistochemical study using antisera directed against rat hypothalamic GRF, J. Comp Neurol. 237(1), 100-115 (1985).
137. D. Fellmann, C. Bugnon, J. Verstegen and G. N. Lavry. Coexpression of human growth hormone-releasing factor 1-37-like and alpha-melanotropin-like immunoreactivities in neurones of the rat lateral dorsal hypothalamus, Neurosci. Lett. 68(1), 122-126 (1986).
138. S. Daikoku, H. Kawano, M. Noguchi, J. Nakanishi, M. Tokuzen, K. Chihara and I. Nagatsu. GRF neurons in the rat hypothalamus, Brain Res. 399(2), 250-261 (1986).
139. J. L. Bresson, M. C. Clavequin, D. Fellmann and C. Bugnon. Human hypothalamic neuronal system revealed with a salmon melanin-concentrating hormone (MCH) antiserum, Neurosci. Lett. 102(1), 39-43 (1989).
140. M. Brownstein, A. Arimura, H. Sato, A. V. Schally and J. S. Kizer. The regional distribution of somatostatin in the rat brain, Endocrinology 96(6), 1456-1461 (1975).
141. R. L. Himsworth, P. W. Carmel and A. G. Frantz. The location of the chemoreceptor controlling growth hormone secretion during hypoglycemia in primates, Endocrinology 91(1), 217-226 (1972).
142. S. H. Russell, M. S. Kim, C. J. Small, C. R. Abbott, D. G. Morgan, S. Taheri, K. G. Murphy, J. F. Todd, M. A. Ghatei and S. R. Bloom. Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin, J. Neuroendocrinol. 12(12), 1213-1218 (2000).
143. L. M. Seoane, S. Tovar, D. Pérez, F. Mallo, M. López, R. Señarís, F. F. Casanueva and C. Diéguez. Orexin A suppresses in vivo GH secretion, Eur. J Endocrinol. 150(5), 731-736 (2004).
144. R. Xu, Q. Wang, M. Yan, M. Hernandez, C. Gong, W. C. Boon, Y. Murata, Y. Ueta and C. Chen. Orexin-A augments voltage-gated Ca2+ currents and synergistically increases growth hormone (GH) secretion with GH-releasing hormone in primary cultured ovine somatotropes, Endocrinology 143(12), 4609-4619 (2002).
145. R. Xu, S. G. Roh, C. Gong, M. Hernandez, Y. Ueta and C. Chen. Orexin-B augments voltage-gated L-type Ca (2+) current via protein kinase C-mediated signalling pathway in ovine somatotropes, Neuroendocrinology 77(3), 141-152 (2003).
146. C. Chen and R. Xu. The in vitro regulation of growth hormone secretion by orexins, Endocrine. 22(1), 57-66 (2003).
147. M. López, L. M. Seoane, S. Tovar, R. Nogueiras, C. Diéguez and R. Señarís. Orexin-A regulates growth hormone releasing hormone mRNA content in a nucleus specific manner and somatostatin mRNA content in a growth hormone-dependent fashion in the rat hypothalamus, Eur. J. Neurosci. 19(8), 2080-2088 (2004).
148. F. Camanni, E. Ghigo and E. Arvat. Growth hormone-releasing peptides and their analogs, Front Neuroendocrinol. 19(1), 47-72 (1998).
149. F. F. Casanueva and C. Diéguez. Growth Hormone Secretagogues: Physiological Role and Clinical Utility, Trends Endocrinol. Metab 10(1), 30-38 (1999).
150. Z. Liposits. Ultrastructure of hypothalamic paraventricular neurons, Crit Rev. Neurobiol. 7(2), 89-162 (1993).
151. V. Rettori, L. Milenkovic, M. C. Aguila and S. M. McCann. Physiologically significant effect of neuropeptide Y to suppress growth hormone release by stimulating somatostatin discharge, Endocrinology 126(5), 2296-2301 (1990).
152. K. Okada, H. Sugihara, S. Minami and I. Wakabayashi. Effect of parenteral administration of selected nutrients and central injection of gamma-globulin from antiserum to neuropeptide Y on growth hormone secretory pattern in food-deprived rats, Neuroendocrinology 57(4), 678-686 (1993).
153. X. J. Cai, P. S. Widdowson, J. Harrold, S. Wilson, R. E. Buckingham, J. R. Arch, M. Tadayyon, J. C. Clapham, J. Wilding and G. Williams. Hypothalamic orexin expression: modulation by blood glucose and feeding, Diabetes 48(11), 2132-2137 (1999).
154. J. T. Willie, R. M. Chemelli, C. M. Sinton, S. Tokita, S. C. Williams, Y. Y. Kisanuki, J. N. Marcus, C. Lee, J. K. Elmquist, K. A. Kohlmeier, C. S. Leonard, J. A. Richardson, R. E. Hammer and M. Yanagisawa. Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes, Neuron 38(5), 715-730 (2003).
155. M. Hayashi, M. Shimohira, S. Saisho, K. Shimozawa and Y. Iwakawa. Sleep disturbance in children with growth hormone deficiency, Brain Dev. 14(3), 170-174 (1992).
156. R. H. Wu and M. J. Thorpy. Effect of growth hormone treatment on sleep EEGs in growth hormonedeficient children, Sleep 11(5), 425-429 (1988).
157. F. Obal, Jr., J. Fang, P. Taishi, B. Kacsoh, J. Gardi and J. M. Krueger. Deficiency of growth hormonereleasing hormone signaling is associated with sleep alterations in the dwarf rat, J. Neurosci. 21(8), 2912-2918 (2001).
158. J. Zhang, F. Obal, Jr., J. Fang, B. J. Collins and J. M. Krueger. Non-rapid eye movement sleep is suppressed in transgenic mice with a deficiency in the somatotropic system, Neurosci. Lett. 220(2), 97-100 (1996).
159. E. Van Cauter, L. Plat and G. Copinschi. Interrelations between sleep and the somatotropic axis, Sleep 21(6), 553-566 (1998).
160. J. Danguir. Intracerebroventricular infusion of somatostatin selectively increases paradoxical sleep in rats, Brain Res. 367(1-2), 26-30 (1986).
161. J. Danguir and K. S. Saint-Hilaire. Reversal of desipramine-induced suppression of paradoxical sleep by a long-acting somatostatin analogue (octreotide) in rats, Neurosci. Lett. 98(2), 154-158 (1989).
162. C. L. Ehlers, T. K. Reed and S. J. Henriksen. Effects of corticotropin-releasing factor and growth hormonereleasing factor on sleep and activity in rats, Neuroendocrinology 42(6), 467-474 (1986).
163. J. Toppila, M. Asikainen, L. Alanko, F. W. Turek, D. Stenberg and T. Porkka-Heiskanen. The effect of REM sleep deprivation on somatostatin and growth hormone-releasing hormone gene expression in the rat hypothalamus, J. Sleep Res. 5(2), 115-122 (1996).
164. J. Toppila, L. Alanko, M. Asikainen, I. Tobler, D. Stenberg and T. Porkka-Heiskanen. Sleep deprivation increases somatostatin and growth hormone-releasing hormone messenger RNA in the rat hypothalamus, J. Sleep Res. 6(3), 171-178 (1997).
165. P. Bourgin, S. Huitron-Resendiz, A. D. Spier, V. Fabre, B. Morte, J. R. Criado, J. G. Sutcliffe, S. J. Henriksen and L. De Lecea. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons, J. Neurosci. 20(20), 7760-7765 (2000).
166. R. W. Clark, H. S. Schmidt and W. B. Malarkey. Disordered growth hormone and prolactin secretion in primary disorders of sleep, Neurology 29(6), 855-861 (1979).
167. T. Higuchi, Y. Takahashi, K. Takahashi, Y. Niimi and A. Miyasita. Twenty-four-hour secretory patterns of growth hormone, prolactin, and cortisol in narcolepsy, J Clin. Endocrinol. Metab 49(2), 197-204 (1979).
168. S. Overeem, S. W. Kok, G. J. Lammers, A. A. Vein, M. Frolich, A. E. Meinders, F. Roelfsema and H. Pijl. Somatotropic axis in hypocretin-deficient narcoleptic humans: altered circadian distribution of GH-secretory events, Am. J. Physiol Endocrinol. Metab 284(3), E641-E647 (2003).
169. L. M. Seoane, M. López, S. Tovar, F. Casanueva, R. Señarís and C. Diéguez. Agouti-related peptide, neuropeptide Y, and somatostatin-producing neurons are targets for ghrelin actions in the rat hypothalamus, Endocrinology 144 544-551 (2003).
170. T. L. Powley and R. E. Keesey. Relationship of body weight to the lateral hypothalamic feeding syndrome, J Comp Physiol Psychol. 70(1), 25-36 (1970).
171. R. F. Drewett. The meal patterns of the oestrous cycle and their motivational significance, Q. J Exp. Psychol. 26(Pt3), 489-494 (1974).
172. J. D. Blaustein and G. N. Wade. Ovarian influences on the meal patterns of female rats, Physiol Behav. 17(2), 201-208 (1976).
173. D. M. Nance and R. A. Gorski. Neurohormonal determinants of sex differences in the hypothalamic regulation of feeding behavior and body weight in the rat, Pharmacol. Biochem. Behav. 3(Suppl 1), 155-162 (1975).
174. G. C. Sieck, D. M. Nance, J. A. Ramaley, A. N. Taylor and R. A. Gorski. Prepubertal cyclicity in feeding behavior and body weight regulation in the female rat, Physiol Behav. 18(2), 299-305 (1977).
175. H. Saito, H. Kaba, T. Sato, M. Kondo, Y. Takeshima, N. Edashige, K. Seto and M. Kawakami. Influence of electrical stimulation of the hypothalamus on ovarian steroidogenesis in hypophysectomized and adrenalectomized rats, Exp. Clin. Endocrinol. 95(2), 259-261 (1990).
176. S. Hansen, C. Kohler, M. Goldstein and H. V. Steinbusch. Effects of ibotenic acid-induced neuronal degeneration in the medial preoptic area and the lateral hypothalamic area on sexual behavior in the male rat, Brain Res. 239(1), 213-232 (1982).
177. W. L. Benedetti, R. Lozdziejsky, M. A. Sala, J. M. Monti and E. Grino. Blockade of ovulation after atropine implants in the lateral hypothalamus of the rat, Experientia 25(11), 1158-1159 (1969).
178. M. S. Smith and K. L. Grove. Integration of the regulation of reproductive function and energy balance: lactation as a model, Front Neuroendocrinol. 23(3), 225-256 (2002).
179. T. Tamura, M. Irahara, M. Tezuka, M. Kiyokawa and T. Aono. Orexins, orexigenic hypothalamic neuropeptides, suppress the pulsatile secretion of luteinizing hormone in ovariectomized female rats, Biochem. Biophys. Res. Commun. 264(3), 759-762 (1999).
180. A. Kohsaka, H. Watanobe, Y. Kakizaki, T. Suda and H. B. Schioth. A significant participation of orexin-A, a potent orexigenic peptide, in the preovulatory luteinizing hormone and prolactin surges in the rat, Brain Res. 898(1), 166-170 (2001).
181. M. Furuta, T. Funabashi and F. Kimura. Suppressive action of orexin A on pulsatile luteinizing hormone secretion is potentiated by a low dose of estrogen in ovariectomized rats, Neuroendocrinology 75(3), 151-157 (2002).
182. C. J. Small, M. L. Goubillon, J. F. Murray, A. Siddiqui, S. E. Grimshaw, H. Young, V. Sivanesan, T. Kalamatianos, A. R. Kennedy, C. W. Coen, S. R. Bloom and C. A. Wilson. Central orexin A has sitespecific effects on luteinizing hormone release in female rats, Endocrinology 144(7), 3225-3236 (2003).
183. M. S. Mondal, M. Nakazato, Y. Date, N. Murakami, M. Yanagisawa and S. Matsukura. Widespread distribution of orexin in rat brain and its regulation upon fasting, Biochem. Biophys. Res. Commun. 256(3), 495-499 (1999).
184. M. L. Hakansson, H. Brown, N. Ghilardi, R. C. Skoda and B. Meister. Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus, J. Neurosci. 18(1), 559-572 (1998).
185. M. Hakansson, L. De Lecea, J. G. Sutcliffe, M. Yanagisawa and B. Meister. Leptin receptor- and STAT3-immunoreactivities in hypocretin/orexin neurones of the lateral hypothalamus, J. Neuroendocrinol. 11(8), 653-663 (1999).
186. J. Iqbal, S. Pompolo, T. Murakami, E. Grouzmann, T. Sakurai, B. Meister and I. J. Clarke. Immunohistochemical characterization of localization of long-form leptin receptor (OB-Rb) in neurochemically defined cells in the ovine hypothalamus, Brain Res. 920(1-2), 55-64 (2001).
187. B. Beck and S. Richy. Hypothalamic hypocretin/orexin and neuropeptide Y: divergent interaction with energy depletion and leptin, Biochem. Biophys. Res. Commun. 258(1), 119-122 (1999).
188. A. Yamanaka, C. T. Beuckmann, J. T. Willie, J. Hara, N. Tsujino, M. Mieda, M. Tominaga, K. Yagami, F. Sugiyama, K. Goto, M. Yanagisawa and T. Sakurai. Hypothalamic orexin neurons regulate arousal according to energy balance in mice, Neuron 38(5), 701-713 (2003).
189. T. Moriguchi, T. Sakurai, T. Nambu, M. Yanagisawa and K. Goto. Neurons containing orexin in the lateral hypothalamic area of the adult rat brain are activated by insulin-induced acute hypoglycemia, Neurosci. Lett. 264(1-3), 101-104 (1999).
190. B. Griffond, P. Y. Risold, C. Jacquemard, C. Colard and D. Fellmann. Insulin-induced hypoglycemia increases preprohypocretin (orexin) mRNA in the rat lateral hypothalamic area, Neurosci. Lett. 262(2), 77-80 (1999).
191. X. H. Liu, R. Morris, D. Spiller, M. White and G. Williams. Orexin a preferentially excites glucosesensitive neurons in the lateral hypothalamus of the rat in vitro, Diabetes 50(11), 2431-2437 (2001).
192. X. J. Cai, X. H. Liu, M. Evans, J. C. Clapham, S. Wilson, J. R. Arch, R. Morris and G. Williams. Orexins and feeding: special occasions or everyday occurrence?, Regul. Pept. 104(1-3), 1-9 (2002).
193. R. M. Boyar, R. S. Rosenfeld, S. Kapen, J. W. Finkelstein, H. P. Roffwarg, E. D. Weitzman and L. Hellman. Human puberty. Simultaneous augmented secretion of luteinizing hormone and testosterone during sleep, J Clin. Invest 54(3), 609-618 (1974).
194. P. K. Opstad and A. Aakvaag. Decreased serum levels of oestradiol, testosterone and prolactin during prolonged physical strain and sleep deprivation, and the influence of a high calorie diet, Eur. J Appl. Physiol Occup. Physiol 49(3), 343-348 (1982).
195. V. Cortes-Gallegos, G. Castaneda, R. Alonso, I. Sojo, A. Carranco, C. Cervantes and A. Parra. Sleep deprivation reduces circulating androgens in healthy men, Arch. Androl 10(1), 33-37 (1983).
196. Y. Touitou, O. Benoit, J. Foret, A. Aguirre, A. Bogdan, M. Clodore and C. Touitou. Effects of a two-hour early awakening and of bright light exposure on plasma patterns of cortisol, melatonin, prolactin and testosterone in man, Acta Endocrinol. (Copenh) 126(3), 201-205 (1992).
197. K. Opstad. Circadian rhythm of hormones is extinguished during prolonged physical stress, sleep and energy deficiency in young men, Eur. J Endocrinol. 131(1), 56-66 (1994).
198. F. Singer and B. Zumoff. Subnormal serum testosterone levels in male internal medicine residents, Steroids 57(2), 86-89 (1992).
199. R. M. Chemelli, J. T. Willie, C. M. Sinton, J. K. Elmquist, T. Scammell, C. Lee, J. A. Richardson, S. C. Williams, Y. Xiong, Y. Kisanuki, T. E. Fitch, M. Nakazato, R. E. Hammer, C. B. Saper and M. Yanagisawa. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation, Cell 98(4), 437-451 (1999).
200. O. Johren, S. J. Neidert, M. Kummer and P. Dominiak. Sexually dimorphic expression of prepro-orexin mRNA in the rat hypothalamus, Peptides 23(6), 1177-1180 (2002).
201. S. Taheri, M. Mahmoodi, J. Opacka-Juffry, M. A. Ghatei and S. R. Bloom. Distribution and quantification of immunoreactive orexin A in rat tissues, FEBS Lett. 457(1), 157-161 (1999).
202. M. C. García, M. López, O. Gualillo, L. Seoane, C. Diéguez and R. Señarís. Hypothalamic levels of NPY, MCH, and prepro-orexin mRNA during pregnancy and lactation in the rat: role of prolactin, FASEB J. 17(11), 1392-1400 (2003).
203. J. B. Wang, T. Murata, K. Narita, K. Honda and T. Higuchi. Variation in the expression of orexin and orexin receptors in the rat hypothalamus during the estrous cycle, pregnancy, parturition, and lactation, Endocrine. 22(2), 127-134 (2003).
204. Z. A. Archer, P. A. Findlay, S. M. Rhind, J. G. Mercer and C. L. Adam. Orexin gene expression and regulation by photoperiod in the sheep hypothalamus, Regul. Pept. 104(1-3), 41-45 (2002).
205. D. N. Jones, J. Gartlon, F. Parker, S. G. Taylor, C. Routledge, P. Hemmati, R. P. Munton, T. E. Ashmeade, J. P. Hatcher, A. Johns, R. A. Porter, J. J. Hagan, A. J. Hunter and N. Upton. Effects of centrally administered orexin-B and orexin-A: a role for orexin-1 receptors in orexin-B-induced hyperactivity, Psychopharmacology (Berl) 153(2), 210-218 (2001).
206. T. Yamamoto, H. Suzuki, H. Uemura, K. Yamamoto and S. Kikuyama. Localization of orexin-A-like immunoreactivity in prolactin cells in the bullfrog (Rana catesbeiana) pituitary, Gen. Comp Endocrinol. 135(2), 186-192 (2004).
207. U. Beck and D. Marquetand. Effects of selective sleep deprivation on sleep-linked prolactin and growth hormone secretion, Arch. Psychiatr. Nervenkr. 223(1), 35-44 (1976).
208. U. Beck. Hormonal secretion during sleep in man. Modification of growth hormone and prolactin secretion by interruption and selective deprivation of sleep, Int. J Neurol. 15(1-2), 17-29 (1981).
209. A. Steiger. Sleep and endocrine regulation, Front Biosci. 8 s358-s376 (2003).
210. C. A. Everson and W. R. Crowley. Reductions in circulating anabolic hormones induced by sustained sleep deprivation in rats, Am. J Physiol Endocrinol. Metab (2004).
211. S. Q. Zhang, M. Kimura and S. Inoue. Effects of prolactin on sleep in cyclic rats, Psychiatry Clin. Neurosci. 53(2), 101-103 (1999).
212. M. S. Smith. Site of action of prolactin in the suppression of gonadotropin secretion during lactation in the rat: effect on pituitary responsiveness to LHRH, Biol. Reprod. 24(5), 967-976 (1981).
213. K. Fujita. Changes of the finer structures in the cells of the thyroid gland induced by electrical stimulation of the hypothalamus in rabbits, Proc Doctor's Treatises, Osaka Univ F-10 (1947).
214. J. R. Davis. Decreased metabolic rates contingent upon lateral hypothalamic lesion-induced body weight losses in male rats., J Comp Physiol Psychol. 91 1019-1031 (1977).
215. T. Kurotsu. Changes of the finer structures of the different gland cells induced by electrical stimulation of the hypothalamus, Med. J. Osaka Univ. 5(87), 104 (1954).
216. L. N. Kaufman, S. W. Corbett and R. E. Keesey. Relationship of thyroid hormones and norepinephrine to the lateral hypothalamic syndrome, Metabolism 35(9), 847-851 (1986).
217. T. Suzuki, H. Kohno, T. Sakurada, T. Tadano and K. Kisara. Intracranial injection of thyrotropin releasing hormone (TRH) suppresses starvation-induced feeding and drinking in rats, Pharmacol. Biochem. Behav. 17(2), 249-253 (1982).
218. T. Mitsuma, Y. Hirooka, Y. Mori, M. Kayama, K. Adachi, N. Rhue, J. Ping and T. Nogimori. Effects of orexin A on thyrotropin-releasing hormone and thyrotropin secretion in rats, Horm. Metab Res. 31(11), 606-609 (1999).
219. S. H. Russell, C. J. Small, D. Sunter, I. Morgan, C. L. Dakin, M. A. Cohen and S. R. Bloom. Chronic intraparaventricular nuclear administration of orexin A in male rats does not alter thyroid axis or uncoupling protein-1 in brown adipose tissue, Regul. Pept. 104(1-3), 61-68 (2002).
220. M. S. Kim, C. J. Small, S. A. Stanley, D. G. Morgan, L. J. Seal, W. M. Kong, C. M. Edwards, S. Abusnana, D. Sunter, M. A. Ghatei and S. R. Bloom. The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin, J. Clin. Invest 105(7), 1005-1011 (2000).
221. M. Lubkin and A. Stricker-Krongrad. Independent feeding and metabolic actions of orexins in mice, Biochem. Biophys. Res. Commun. 253(2), 241-245 (1998).
222. A. Asakawa, A. Inui, K. Goto, H. Yuzuriha, Y. Takimoto, T. Inui, G. Katsuura, M. A. Fujino, M. M. Meguid and M. Kasuga. Effects of agouti-related protein, orexin and melanin-concentrating hormone on oxygen consumption in mice, Int. J Mol. Med. 10(4), 523-525 (2002).
223. J. Wang, T. Osaka and S. Inoue. Energy expenditure by intracerebroventricular administration of orexin to anesthetized rats, Neurosci. Lett. 315(1-2), 49-52 (2001).
224. J. Hara, C. T. Beuckmann, T. Nambu, J. T. Willie, R. M. Chemelli, C. M. Sinton, F. Sugiyama, K. Yagami, K. Goto, M. Yanagisawa and T. Sakurai. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity, Neuron 30(2), 345-354 (2001).
225. G. J. Lammers, H. Pijl, J. Iestra, J. A. Langius, G. Buunk and A. E. Meinders. Spontaneous food choice in narcolepsy, Sleep 19(1), 75-76 (1996).
226. T. Sakurai. Roles of orexins in the regulation of feeding and arousal, Sleep Med. 3(Suppl 2) S3-S9 (2002).
227. A. Schuld, J. Hebebrand, F. Geller and T. Pollmacher. Increased body-mass index in patients with narcolepsy, Lancet 355(9211), 1274-1275 (2000).
228. M. López, L. Seoane, R. Señarís and C. Diéguez. Prepro-orexin mRNA levels in the rat hypothalamus, and orexin receptors mRNA levels in the rat hypothalamus and adrenal gland are not influenced by the thyroid status, Neurosci. Lett. 300(3), 171-175 (2001).
229. S. Ishii, J. Kamegai, H. Tamura, T. Shimizu, H. Sugihara and S. Oikawa. Hypothalamic neuropeptide Y/Y1 receptor pathway activated by a reduction in circulating leptin, but not by an increase in circulating ghrelin, contributes to hyperphagia associated with triiodothyronine-induced thyrotoxicosis, Neuroendocrinology 78(6), 321-330 (2003).
230. A. B. Steffens. The modulatory effect of the hypothalamus on glucagon and insulin secretion in the rat, Diabetologia 20(Suppl) 411-416 (1981).
231. J. H. Strubbe and A. B. Steffens. Rapid insulin release after ingestion of a meal in the unanesthetized rat, Am. J Physiol 229(4), 1019-1022 (1975).
232. M. G. Tordoff, C. V. Grijalva, D. Novin, L. L. Butcher, J. H. Walsh, F. X. Pi-Sunyer and D. A. Vander Weele. Influence of sympathectomy on the lateral hypothalamic lesion syndrome, Behav. Neurosci. 98(6), 1039-1059 (1984).
233. C. V. Grijalva, D. Novin and G. A. Bray. Alterations in blood glucose, insulin and free fatty acids following lateral hypothalamic lesions and parasagittal knife cuts, Brain Res. Bull. 5(Suppl 4), 109-117 (1980).
234. L. L. Bernardis, L. L. Bellinger and A. Awad. Metabolic-endocrine correlates of the lateral hypothalamic syndrome: the first 48 hours, Pharmacol. Biochem. Behav. 37(3), 393-398 (1990).
235. A. M. Helman, P. Giraud, S. Nicolaidis, C. Oliver and R. Assan. Glucagon release after stimulation of the lateral hypothalamic area in rats: predominant beta-adrenergic transmission and involvement of endorphin pathways, Endocrinology 113(1), 1-6 (1983).
236. R. M. Buijs, S. J. Chun, A. Niijima, H. J. Romijn and K. Nagai. Parasympathetic and sympathetic control of the pancreas: a role for the suprachiasmatic nucleus and other hypothalamic centers that are involved in the regulation of food intake, J. Comp Neurol. 431(4), 405-423 (2001).
237. X. Wu, J. Gao, J. Yan, C. Owyang and Y. Li. Hypothalamus-brainstem circuitry responsible for vagal efferent signaling to the pancreas evoked by hypoglycemia in rat, J Neurophysiol. 91(4), 1734-1747 (2004).
238. K. Miyasaka, M. Masuda, S. Kanai, N. Sato, M. Kurosawa and A. Funakoshi. Central Orexin-A stimulates pancreatic exocrine secretion via the vagus, Pancreas 25(4), 400-404 (2002).
239. A. J. Kastin and V. Akerstrom. Orexin A but not orexin B rapidly enters brain from blood by simple diffusion, J. Pharmacol. Exp. Ther. 289(1), 219-223 (1999).
240. K. W. Nowak, P. Mackowiak, M. M. Switonska, M. Fabis and L. K. Malendowicz. Acute orexin effects on insulin secretion in the rat: in vivo and in vitro studies, Life Sci. 66(5), 449-454 (2000).
241. D. G. Baskin, L. D. Figlewicz, R. J. Seeley, S. C. Woods, D. Porte, Jr. and M. W. Schwartz. Insulin and leptin: dual adiposity signals to the brain for the regulation of food intake and body weight, Brain Res. 848(1-2), 114-123 (1999).
242. M. W. Schwartz, S. C. Woods, D. Porte, Jr., R. J. Seeley and D. G. Baskin. Central nervous system control of food intake, Nature 404(6778), 661-671 (2000).
243. G. Grabauskas and H. C. Moises. Gastrointestinal-projecting neurones in the dorsal motor nucleus of the vagus exhibit direct and viscerotopically organized sensitivity to orexin, J Physiol 549(Pt 1), 37-56 (2003).
244. G. Burdyga, S. Lal, D. Spiller, W. Jiang, D. Thompson, S. Attwood, S. Saeed, D. Grundy, A. Varro, R. Dimaline and G. J. Dockray. Localization of orexin-1 receptors to vagal afferent neurons in the rat and humans, Gastroenterology 124(1), 129-139 (2003).
245. N. Takahashi, T. Okumura, H. Yamada and Y. Kohgo. Stimulation of gastric acid secretion by centrally administered orexin-A in conscious rats, Biochem. Biophys. Res. Commun. 254(3), 623-627 (1999).
246. M. Kobashi, Y. Furudono, R. Matsuo and T. Yamamoto. Central orexin facilitates gastric relaxation and contractility in rats, Neurosci. Lett. 332(3), 171-174 (2002).
247. K. Matsuo, M. Kaibara, Y. Uezono, H. Hayashi, K. Taniyama and Y. Nakane. Involvement of cholinergic neurons in orexin-induced contraction of guinea pig ileum, Eur. J. Pharmacol. 452(1), 105 (2002).
248. M. A. Greer. Suggestive evidence of a primary drinking center in hypothalamus of the rat, Proc. Soc. Exp. Biol. Med. 89(1), 59-62 (1955).
249. N. Rowland. Recovery of regulatory drinking following lateral hypothalamic lesions: nature of residual deficits analyzed by NaCl and water infusions, Exp. Neurol. 53(2), 488-507 (1976).
250. J. F. Marshall and P. Teitelbaum. Further analysis of sensory inattention following lateral hypothalamic damage in rats, J Comp Physiol Psychol. 86(3), 375-395 (1974).
251. G. A. Oltmans and J. A. Harvey. Lateral hypothalamic syndrome in rats: a comparison of the behavioral and neurochemical effects of lesions placed in the lateral hypothalamus and nigrostriatal bundle, J Comp Physiol Psychol. 90(11), 1051-1062 (1976).
252. K. Kunii, A. Yamanaka, T. Nambu, I. Matsuzaki, K. Goto and T. Sakurai. Orexins/hypocretins regulate drinking behaviour, Brain Res. 842(1), 256-261 (1999).